<DOC>
	<DOCNO>NCT02151747</DOCNO>
	<brief_summary>Testing BRCA 1/2 mutation important patient breast cancer , Sanger sequence standard method identify BRCA 1/2 mutation . Next generation sequencing ( NGS ) high-throughput parallel sequence provide genetic information high accuracy . NGS faster cost-effective method detect gene mutation compare Sanger sequence . In study , evaluate clinical role NGS test BRCA 1/2 compare Sanger sequence .</brief_summary>
	<brief_title>Testing BRCA 1/2 Mutation Using Next Generation Sequencing</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>Age &gt; 18 Breast ovarian cancer history 2nd degree family member Male breast cancer Bilateral breast cancer Patient breast cancer 40 year age Simultaneous breast ovarian cancer Patients epithelial ovarian cancer Breast cancer simultaneous extramammary malignancy Patients agree test BRCA 1/2 mutation</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>breast neoplasm , BRCA1 , Sanger , NGS , Next generation sequence</keyword>
</DOC>